Ostia Sciences Inc.
PrivateLast Round
Seed
Jul 18, 2025
Total Funding Raised
$2.48M
Momentum Score
25 /100
Company Overview
Ostia Sciences Inc. is a biotechnology company that develops innovative oral probiotics and biotherapeutics for improving global health outcomes.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Government Contracts, Revenue Share
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Ostia Sciences Inc. Comps
Public and private peers based on sector, stage, and business model.
Ostia Sciences Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Jul 18, 2025 | ||||
| Seed | Dec 31, 2024 |
Key People
Founding team and executive leadership
Ostia Sciences Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Natural Products Canada | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 20, 2026
Received hands-on support from Invest Ontario for provincial expansion.
- Apr 20, 2026
A new $12 million project will accelerate growth with new offices in Ontario, Canada.
Ostia Sciences Inc. Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Ostia Sciences Inc.'s valuation, stock price, and market status.
